Ventas (NYSE:VTR) Price Target Raised to $93.00 at JPMorgan Chase & Co.

Ventas (NYSE:VTRGet Free Report) had its price objective boosted by investment analysts at JPMorgan Chase & Co. from $88.00 to $93.00 in a research note issued to investors on Friday,Benzinga reports. The brokerage currently has an “overweight” rating on the real estate investment trust’s stock. JPMorgan Chase & Co.‘s price objective would suggest a potential upside of 12.47% from the company’s previous close.

A number of other equities research analysts have also recently commented on the stock. Argus set a $88.00 price objective on shares of Ventas in a research note on Tuesday, February 10th. UBS Group reissued a “neutral” rating and set a $85.00 price objective on shares of Ventas in a research note on Monday, February 9th. Cantor Fitzgerald restated an “overweight” rating and issued a $93.00 price target on shares of Ventas in a report on Monday, February 9th. Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Monday, December 29th. Finally, Mizuho upped their price target on shares of Ventas from $87.00 to $94.00 and gave the company an “outperform” rating in a report on Wednesday, March 4th. Thirteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, Ventas has a consensus rating of “Moderate Buy” and an average price target of $90.13.

View Our Latest Stock Analysis on VTR

Ventas Stock Down 3.3%

Shares of VTR traded down $2.86 during midday trading on Friday, reaching $82.69. The stock had a trading volume of 2,441,789 shares, compared to its average volume of 2,982,637. The company has a debt-to-equity ratio of 1.03, a current ratio of 0.67 and a quick ratio of 0.67. The company’s fifty day simple moving average is $82.36 and its two-hundred day simple moving average is $76.86. The company has a market cap of $39.27 billion, a price-to-earnings ratio of 152.91, a PEG ratio of 2.16 and a beta of 0.73. Ventas has a 1-year low of $60.15 and a 1-year high of $88.36.

Ventas (NYSE:VTRGet Free Report) last announced its quarterly earnings results on Thursday, February 5th. The real estate investment trust reported $0.15 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.74). The company had revenue of ($1,229.71) million during the quarter, compared to analysts’ expectations of $1.53 billion. Ventas had a net margin of 4.31% and a return on equity of 2.09%. The business’s revenue for the quarter was up 21.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.81 earnings per share. Ventas has set its FY 2026 guidance at 3.780-3.880 EPS. Equities research analysts expect that Ventas will post 3.4 earnings per share for the current year.

Insiders Place Their Bets

In related news, CFO Robert F. Probst sold 29,930 shares of the company’s stock in a transaction dated Friday, January 2nd. The shares were sold at an average price of $77.25, for a total value of $2,312,092.50. Following the completion of the sale, the chief financial officer owned 138,434 shares of the company’s stock, valued at $10,694,026.50. This represents a 17.78% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Carey S. Roberts sold 35,532 shares of the company’s stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $85.00, for a total transaction of $3,020,220.00. Following the completion of the sale, the executive vice president directly owned 72,755 shares of the company’s stock, valued at $6,184,175. The trade was a 32.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders sold 86,106 shares of company stock worth $6,931,397. 0.80% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in VTR. Bridgewater Advisors Inc. lifted its stake in Ventas by 2.0% in the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after acquiring an additional 133 shares in the last quarter. Arbor Capital Management Inc. ADV increased its position in Ventas by 0.6% during the third quarter. Arbor Capital Management Inc. ADV now owns 21,716 shares of the real estate investment trust’s stock worth $1,520,000 after buying an additional 137 shares during the last quarter. IHT Wealth Management LLC raised its stake in shares of Ventas by 3.2% in the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock valued at $343,000 after acquiring an additional 137 shares in the last quarter. True Wealth Design LLC lifted its stake in shares of Ventas by 32.0% in the fourth quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after buying an additional 138 shares during the last quarter. Finally, Cigna Investments Inc. New lifted its position in Ventas by 3.3% during the 4th quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock worth $341,000 after acquiring an additional 142 shares during the last quarter. 94.18% of the stock is currently owned by institutional investors.

Ventas Company Profile

(Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Recommended Stories

Analyst Recommendations for Ventas (NYSE:VTR)

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.